Home Newsletters Pulmonary Cell News Clinical, Genetic and Pharmacological Data Support Targeting the MEK5/ERK5 Module in Lung...

Clinical, Genetic and Pharmacological Data Support Targeting the MEK5/ERK5 Module in Lung Cancer

By

-

August 17, 2021

Using genetic as well as pharmacological tools, researchers showed that targeting the MEK5/ERK5 route was therapeutically effective in lung cancer.

[npj Precision Oncology]

Sorry, but the selected Zotpress account can't be found.

Exit mobile version